Advanced search
Publication Cover
Journal of Inflammation Research Volume 12, 2019 - Issue
Submit an article Journal homepage
87
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently

Naoki Sato1 Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan;2 Department of Research Center, Tanabe Pharmacy Inc., Tokyo, Japan
,
Yuya Nakamura1 Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan;3 Department of Nephrology, Saiyu Soka Hospital, Soka City, Saitama-ken, JapanORCID Iconhttps://orcid.org/0000-0002-6156-5975
ORCID Icon,
Shiho Yamadera4 Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan
,
Masahiro Inagaki1 Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan;5 Fuculty of Arts and Sciences at Fujiyoshida, Showa University, Fujiyoshida City, Yamanashi-ken, Japan
,
Sachiyo Kenmotsu5 Fuculty of Arts and Sciences at Fujiyoshida, Showa University, Fujiyoshida City, Yamanashi-ken, Japan
,
Hiroshi Saito4 Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan;6 Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-5184-9181
ORCID Icon,
Tatsunori Oguchi1 Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan
,
Mayumi Tsuji1 Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan
,
Hirokazu Chokki1 Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan
,
Isao Ohsawa3 Department of Nephrology, Saiyu Soka Hospital, Soka City, Saitama-ken, Japan
,
Hiromichi Gotoh3 Department of Nephrology, Saiyu Soka Hospital, Soka City, Saitama-ken, Japan
,
Shinichi Iwai6 Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-2726-0107
ORCID Icon &
Yuji Kiuchi1 Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0001-7198-3735
ORCID Icon show all
Pages 285-291 | Published online: 21 Oct 2019

References

  • Drucker DJ. Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes. Expert Opin Investig Drugs. 2003;12:87–100. doi:10.1517/13543784.12.1.87
  • Blech S, Ludwig-Schwellinger E, Gräfe-Mody EU, Withopf B, Wagner K. The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans. Drug Metab Dispos. 2010;38:667–678. doi:10.1124/dmd.109.03147620086031
  • Hüttner S, Graefe-Mody EU, Withopf B, Ring A, Dugi KA. Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers. J Clin Pharmacol. 2008;48:1171–1178. doi:10.1177/009127000832375318812608
  • Gallwitz B. Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin. Ther Clin Risk Manag. 2015;11:799–805. doi:10.2147/TCRM.S6707625999728
  • Nakamura Y, Hasegawa H, Tsuji M, et al. Linagliptin inhibits lipopolysaccharide-stimulated interleukin-6 production, intranuclear p65 expression, and p38 mitogen-activated protein kinase phosphorylation in human umbilical vein endothelial cells. Ren Replace The. 2016;2:17. doi:10.1186/s41100-016-0030-6
  • Nakamura Y, Inagaki M, Tsuji M, et al. Linagliptin has wide-ranging anti-inflammatory points of action in human umbilical vein endothelial cells. Jpn Clin Med. 2016;7:27–32. doi:10.4137/JCM.S3931727980448
  • Yamadera S, Nakamura Y, Inagaki M, et al. Linagliptin inhibits lipopolysaccharide induced inflammation in human U937 monocytes. Inflamm Regen. 2018;38:13. doi:10.1186/s41232-018-0071-z30151063
  • Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431–1433. doi:10.1126/science.22710621698311
  • Nishijima M, Hara-Kuge S, Takasuka N, et al. Identification of a biochemical lesion, and characteristic response to lipopolysaccharide (LPS) of a cultured macrophage-like cell mutant with defective LPS-binding. J Biochem. 1994;116:1082–1087. doi:10.1093/oxfordjournals.jbchem.a1246317534758
  • Weinstein SL, June CH, DeFranco AL. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J Immunol. 1993;151:3829–3838.7690817
  • Yamamoto Y, Harashima A, Saito H, et al. Septic shock is associated with receptor for advanced glycation end products (RAGE) ligation of LPS. J Immunol. 2011;186:3248–3257. doi:10.4049/jimmunol.100225321270403
  • Gonzalez-Rey E, Chorny A, Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol. 2007;7:52–63. doi:10.1038/nri198417186031
  • Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2011;21:103–115. doi:10.1038/cr.2010.17821187859
  • Boehringer Ingelheim Pharmaceuticals, Inc. Tradjenta (linagliptin) tablets. Available from: http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Tradjenta/Tradjenta.pdf Accessed 319, 2019.
  • Hasegawa H, Nakamura Y, Tsuji M, et al. Sitagliptin inhibits the lipopolysaccharide-induced inflammation. J Pharm Drug Deliv Res. 2016;5:2. doi:10.4172/2325-9604.1000148
  • Nakamura Y, Tsuji M, Hasegawa H, et al. Anti-inflammatory effects of linagliptin in hemodialysis patients with diabetes. Hemodial Int. 2014;18:433–442. doi:10.1111/hdi.1212724405885
  • Varin EM, Mulvihill EE, Beaudry JL, et al. Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition. Cell Metab. 2019;29:320–334.e5. doi:10.1016/j.cmet.2018.10.00130393019

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.